Investors Rights Agreement Sample Contracts

Share Cite Term
Link

Embed (HTML)
CURO Group Holdings Corp. – Amended and Restated Investors Rights Agreement (November 28th, 2017)

This AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT, dated as of [ ], 2017 (this Agreement) among (i) CURO Group Holdings Corp. (the Company), (ii) Freidman Fleischer & Lowe Capital Partners II, L.P., FFL Executive Partners II, L.P. and FFL Parallel Fund II, L.P. (collectively, the FFL Entities), (iii) Chadwick Faulkner (Faulkner) (iv) the Faulkner, Chadwick 2014 GRAT (the Faulkner GRAT) (v) Exempt Family Trust c/u Chadwick H. Faulkner 2017 Dynasty Trust (the C. Faulkner Trust) (vi) Exempt Family Trust c/u/ Leah M. Faulkner 2017 Dynast Trust (together with Faulkner, the Faulkner GRAT and the C. Faulkner Trust, the Faulkner Parties), (vii) Rippel Holdings, LLC (Rippel), (v) McKnight Holdings, LLC (McKnight), (viii) James Ackerman (Ackerman), (ix) Nick Adams (Adams), (x) Matt Miller (Miller) and (xi) the J.P. Genova Family Trust (the Trust).

Ovid Therapeutics Inc. – Second Amended and Restated Investors Rights Agreement (April 10th, 2017)

THIS SECOND AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (this Agreement), is made as of the 6th day of January, 2017, by and among Ovid Therapeutics Inc., a Delaware corporation (the Company), each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an Investor, and each of the stockholders listed on Schedule B hereto, each of whom is referred to herein as a Key Holder.

Coupa Software Inc – Coupa Software Incorporated Waiver of Notice and Registration Rights and Amendment to Amended and Restated Investors Rights Agreement April 8, 2017 (April 10th, 2017)

This WAIVER OF NOTICE AND REGISTRATION RIGHTS AND AMENDMENT TO AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (this Waiver) is entered into by and among Coupa Software Incorporated, a Delaware corporation (the Company), and the undersigned holders (the Holders) of the Companys capital stock.

Biohaven Pharmaceutical Holding Co Ltd. – BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. INVESTORS RIGHTS AGREEMENT October 28, 2016 (April 7th, 2017)

THIS INVESTORS RIGHTS AGREEMENT (this Agreement), is made as of the 28th day of October, 2016, by and among Biohaven Pharmaceutical Holding Ltd., a company formed under the laws of the Territory of the British Virgin Islands (the Company), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an Investor, each of the shareholders listed on Schedule B hereto, each of whom is referred to herein as a Key Holder and any Additional Purchaser (as defined in the Purchase Agreement) that becomes a party to this Agreement in accordance with Section 5.9 hereof.

UroGen Pharma Ltd. – Investors Rights Agreement (April 7th, 2017)

THIS INVESTORS RIGHTS AGREEMENT (the Agreement) is made as of September 18, 2014, by and among TheraCoat Ltd., a private company incorporated under the laws of the State of Israel of, 13 HaSadna St., P.O. Box 2397, Raanana 4365007, Israel (the Company), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an Investor.

Zymeworks Inc. – Investors Rights Agreement (April 3rd, 2017)

THIS INVESTORS RIGHTS AGREEMENT (this Agreement), is made as of January 7, 2016 by and among Zymeworks Inc., a corporation existing under the Canada Business Corporations Act (the Company), and each of the investors listed on Schedule A-1 and Schedule A-2 hereto (each an Investor).

Okta, Inc. – OKTA, INC. AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT July 31, 2015 (March 13th, 2017)

THIS AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (the Agreement) is made as of July 31, 2015, by and among OKTA, INC., a Delaware corporation (the Company) and the investors listed on Schedule A hereto, each of which is herein referred to as an Investor and collectively as the Investors.

Yext, Inc. – Yext, Inc. Fifth Amended and Restated Investors Rights Agreement (March 13th, 2017)

THIS FIFTH AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (this Agreement) is made as of the 28th day of May, 2014, by and among Yext, Inc., a Delaware corporation (the Company), each of the investors listed on Schedule A hereto, each of which (including the Founders (as defined herein) in their capacities as Investors) is referred to in this Agreement as an Investor, and, solely for purposes of the provisions herein relating to Founder Shares (as defined herein), the Founders in their capacities as Founders.

Alteryx, Inc. – Alteryx, Inc. Second Amended and Restated Investors Rights Agreement (February 24th, 2017)

This Second Amended and Restated Investors Rights Agreement (this Agreement) is made and entered into as of September 24, 2015, by and among Alteryx, Inc., a Delaware corporation (the Company); the individuals listed on Exhibit A-1 (each a Principal Stockholder and collectively Principal Stockholders); Sapphire Ventures Fund I, L.P., Toba Capital Fund II, LLC, Teach A Man To Fish Foundation, and the funds affiliated with Insight Venture Management, LLC (Insight) set forth on Exhibit A-2 (the Existing Preferred Holders); Meritech Capital Partners V L.P. and Meritech Capital Affiliates V L.P. (together, the Meritech Investors) and the funds and investment vehicles set forth on Exhibit A-3, (together with any Iconiq Affiliates that hold shares of stock in the Company, the Iconiq Investors and, together with the Meritech Investors and the Existing Preferred Holders, the Investors).

Mulesoft, Inc – MULESOFT, INC. SIXTH AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT May 13, 2015 (February 17th, 2017)

This Sixth Amended and Restated Investors Rights Agreement (this Agreement) is made as of May 13, 2015, by and among MuleSoft, Inc., a Delaware corporation (the Company), and the persons and entities (each, an Investor and collectively, the Investors) listed on Exhibit A hereto. Unless otherwise defined herein, capitalized terms used in this Agreement have the meanings ascribed to them in Section 1.

Biohaven Pharmaceutical Holding Co Ltd. – BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. INVESTORS RIGHTS AGREEMENT October 28, 2016 (February 14th, 2017)

THIS INVESTORS RIGHTS AGREEMENT (this Agreement), is made as of the 28th day of October, 2016, by and among Biohaven Pharmaceutical Holding Ltd., a company formed under the laws of the Territory of the British Virgin Islands (the Company), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an Investor, each of the shareholders listed on Schedule B hereto, each of whom is referred to herein as a Key Holder and any Additional Purchaser (as defined in the Purchase Agreement) that becomes a party to this Agreement in accordance with Section 5.9 hereof.

Ovid Therapeutics Inc. – Second Amended and Restated Investors Rights Agreement (February 3rd, 2017)

THIS SECOND AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (this Agreement), is made as of the 6th day of January, 2017, by and among Ovid Therapeutics Inc., a Delaware corporation (the Company), each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an Investor, and each of the stockholders listed on Schedule B hereto, each of whom is referred to herein as a Key Holder.

Yext, Inc. – Yext, Inc. Fifth Amended and Restated Investors Rights Agreement (January 24th, 2017)

THIS FIFTH AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (this Agreement) is made as of the 28th day of May, 2014, by and among Yext, Inc., a Delaware corporation (the Company), each of the investors listed on Schedule A hereto, each of which (including the Founders (as defined herein) in their capacities as Investors) is referred to in this Agreement as an Investor, and, solely for purposes of the provisions herein relating to Founder Shares (as defined herein), the Founders in their capacities as Founders.

Jounce Therapeutics, Inc. – Jounce Therapeutics, Inc. Amended and Restated Investors Rights Agreement (December 30th, 2016)

THIS AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Agreement) is made as of April 17, 2015, by and among Jounce Therapeutics, Inc., a Delaware corporation (the Company), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an Investor.

Appdynamics Inc – Appdynamics, Inc. Sixth Amended and Restated Investors Rights Agreement (December 28th, 2016)

This Sixth Amended and Restated Investors Rights Agreement (this Agreement) is made as of November 8, 2015, by and among AppDynamics, Inc., a Delaware corporation (the Company), and the persons and entities (each, an Investor and collectively, the Investors) listed on Exhibit A hereto. Unless otherwise defined herein, capitalized terms used in this Agreement have the meanings ascribed to them in Section 1.

Okta, Inc. – OKTA, INC. AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT July 31, 2015 (December 20th, 2016)

THIS AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (the Agreement) is made as of July 31, 2015, by and among OKTA, INC., a Delaware corporation (the Company) and the investors listed on Schedule A hereto, each of which is herein referred to as an Investor and collectively as the Investors.

Zymeworks Inc. – Investors Rights Agreement (December 13th, 2016)

THIS INVESTORS RIGHTS AGREEMENT (this Agreement), is made as of January 7, 2016 by and among Zymeworks Inc., a corporation existing under the Canada Business Corporations Act (the Company), and each of the investors listed on Schedule A-1 and Schedule A-2 hereto (each an Investor).

Alteryx, Inc. – Alteryx, Inc. Second Amended and Restated Investors Rights Agreement (December 8th, 2016)

This Second Amended and Restated Investors Rights Agreement (this Agreement) is made and entered into as of September 24, 2015, by and among Alteryx, Inc., a Delaware corporation (the Company); the individuals listed on Exhibit A-1 (each a Principal Stockholder and collectively Principal Stockholders); Sapphire Ventures Fund I, L.P., Toba Capital Fund II, LLC, Teach A Man To Fish Foundation, and the funds affiliated with Insight Venture Management, LLC (Insight) set forth on Exhibit A-2 (the Existing Preferred Holders); Meritech Capital Partners V L.P. and Meritech Capital Affiliates V L.P. (together, the Meritech Investors) and the funds and investment vehicles set forth on Exhibit A-3, (together with any Iconiq Affiliates that hold shares of stock in the Company, the Iconiq Investors and, together with the Meritech Investors and the Existing Preferred Holders, the Investors).

Mulesoft, Inc – MULESOFT, INC. SIXTH AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT May 13, 2015 (November 18th, 2016)

This Sixth Amended and Restated Investors Rights Agreement (this Agreement) is made as of May 13, 2015, by and among MuleSoft, Inc., a Delaware corporation (the Company), and the persons and entities (each, an Investor and collectively, the Investors) listed on Exhibit A hereto. Unless otherwise defined herein, capitalized terms used in this Agreement have the meanings ascribed to them in Section 1.

Angie's List Inc. – Amendment No. 1 to Amended and Restated Investors' Rights Agreement (November 2nd, 2016)

This Amendment No. 1 (the "First Amendment"), dated November 1, 2016, by and between Angie's List, Inc. (the "Company") and TRI Investments, LLC ("TRI"), and amends that certain Amended and Restated Investors' Rights Agreement dated March 15, 2011 by and among the Company and investors listed on Schedule A thereto (the "Investors' Rights Agreement"). TRI owns at least 67% of the Registrable Securities. Unless otherwise defined herein, capitalized terms used in this First Amendment shall have the meanings given to them in the Investors' Rights Agreement.

Jounce Therapeutics, Inc. – Jounce Therapeutics, Inc. Amended and Restated Investors Rights Agreement (October 12th, 2016)

THIS AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Agreement) is made as of April 17, 2015, by and among Jounce Therapeutics, Inc., a Delaware corporation (the Company), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an Investor.

Neighborhood Connections – Third Amended and Restated Investors Rights Agreement (October 11th, 2016)

This THIRD AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (this Agreement) is made and entered into as of September 8, 2016 by and among APOLLO ENDOSURGERY, INC., a Delaware corporation (the Company) and the investors listed on Exhibit A attached to this Agreement (the Investors).

Horizon Global Corp – Investors Rights Agreement (October 11th, 2016)

THIS INVESTORS RIGHTS AGREEMENT (this Agreement) is made and entered into as of the 4th day of October, 2016, by and between Horizon Global Corporation, a Delaware corporation (the Company), and Parcom Deutschland I GmbH & Co. KG, a German limited partnership with a limited liability company as general partner (the Investor).

iRhythm Technologies, Inc. – IRHYTHM TECHNOLOGIES, INC. AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT May 16, 2014 (October 7th, 2016)

This Amended and Restated Investors Rights Agreement (this Agreement) is made as of May 16, 2014, by and among iRhythm Technologies, Inc., a Delaware corporation (the Company), and the persons and entities (each, an Investor and collectively, the Investors) listed on Exhibit A hereto. Unless otherwise defined herein, capitalized terms used in this Agreement have the meanings ascribed to them in Section 1.

Ra Pharmaceuticals, Inc. – Ra Pharmaceuticals, Inc. Amended and Restated Investors Rights Agreement (September 30th, 2016)

THIS AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT is made as of the 10th day of July, 2015 by and among Ra Pharmaceuticals, Inc., a Delaware corporation (the Company) and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an Investor.

Quantenna Communications Inc – Amended and Restated Investors' Rights Agreement (September 29th, 2016)

This Amended and Restated Investors' Rights Agreement (this "Agreement") is made as of August 29, 2014, by and among Quantenna Communications, Inc., a Delaware corporation (the "Company"), the persons and entities listed on Exhibit A hereto (each a "Lender," and collectively the "Lenders"), the persons and entities listed on Exhibit B hereto (each an "Investor" and collectively, as the "Investors") and the persons listed on Exhibit C hereto (each a "Founder," and collectively the "Founders"). Unless otherwise defined herein, capitalized terms used in this Agreement have the meanings ascribed to them in Section 1. The Founders are party to this Agreement for purposes of Sections 1, 2.2, 2.4 through 2.14 and 5 hereof only. The Lenders are party to this Agreement for purposes of Sections 1, 2.2 through 2.14 and 5 hereof only.

iRhythm Technologies, Inc. – IRHYTHM TECHNOLOGIES, INC. AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT May 16, 2014 (September 23rd, 2016)

This Amended and Restated Investors Rights Agreement (this Agreement) is made as of May 16, 2014, by and among iRhythm Technologies, Inc., a Delaware corporation (the Company), and the persons and entities (each, an Investor and collectively, the Investors) listed on Exhibit A hereto. Unless otherwise defined herein, capitalized terms used in this Agreement have the meanings ascribed to them in Section 1.

Obalon Therapeutics Inc – Fourth Amended and Restated Investors Rights Agreement (September 9th, 2016)

THIS FOURTH AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (the Agreement) is entered into as of April 29, 2016 by Obalon Therapeutics, Inc., a Delaware corporation (the Company), the persons and entities listed on Exhibit A attached hereto (the Investors) and the persons and entities listed on Exhibit B attached hereto (the Stockholders).

Everspin Technologies Inc – Everspin Technologies, Inc. Amended and Restated Investors Rights Agreement (September 9th, 2016)

THIS AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (the Agreement) is made as of this 21st day October, 2014, by and among Everspin Technologies, Inc., a Delaware corporation (the Company), the individuals and entities listed on Schedule A hereto (each, an Investor, and collectively, the Investors), Freescale Semiconductor, Inc. (the Key Holder), and any Additional Purchaser (as defined in the Purchase Agreement) that becomes a party to this Agreement in accordance with Section 6.9 hereof.

Coupa Software Inc – Amended and Restated Investors Rights Agreement (September 8th, 2016)

THIS AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (the Agreement) is made as of May 26, 2015, by and among COUPA SOFTWARE INCORPORATED, a Delaware corporation (the Company), the investors listed on Schedule A hereto, each of which is herein referred to as an Investor and the holders of Common Stock listed on Schedule B hereto, each of which is herein referred to as a Common Holder.

Trade Desk, Inc. – The Trade Desk, Inc. Second Amended and Restated Investors Rights Agreement (September 6th, 2016)

This Second Amended and Restated Investors Rights Agreement (the Agreement) is made as of February 9, 2016, by and among (i) The Trade Desk, Inc., a Delaware corporation (the Company), (ii) the parties listed under the heading Investors on Exhibit A hereto (each, an Investor and together, the Investors) and (iii) the parties listed under the heading Founders on Exhibit A hereto (each, a Founder and together the Founders).

Fulgent Diagnostics, Inc. – Fulgent Therapeutics Llc Investors Rights Agreement (September 2nd, 2016)

THIS INVESTORS RIGHTS AGREEMENT (this Agreement) is entered into effective as of May 17, 2016, by and between Fulgent Therapeutics LLC, a California limited liability company (the Company), and Xi Long USA, Inc., a Delaware corporation (the Investor). The Company and the Investor are sometimes collectively referred to herein as the Parties and individually as a Party.

Apptio Inc – Apptio, Inc. Amendment to Amended and Restated Investors Rights Agreement (August 26th, 2016)

This Amendment to Amended and Restated Investors Agreement (this Amendment) dated as of October 11, 2013 is made by and among Apptio, Inc., a Delaware corporation (the Company) and the undersigned Requisite Investors (as defined below). This Amendment amends the Amended and Restated Investors Rights Agreement dated May 3, 2013 (the Agreement) by and among the Company, the investors listed on Exhibit A thereto (each of which is herein referred to as an Investor and collectively, the Investors) and Sachin Gupta, Gupta Family Irrevocable Trust, Kurt Shintaffer, KCS 2012 GRAT, KDS 2012 GRAT, Paul McLachlan, Jesse Lee and Brian Bero, each of whom is herein referred to as a Founder. All capitalized terms used but not defined in this Amendment shall have the meanings assigned to such terms in the Agreement.

Apptio Inc – Apptio, Inc. Amended and Restated Investors Rights Agreement (August 26th, 2016)

This Amended and Restated Investors Rights Agreement (the Agreement) is made as of the 3rd day of May, 2013, by and among Apptio, Inc., a Delaware corporation (the Company), the investors listed on Exhibit A hereto (each of which is herein referred to as an Investor and collectively, the Investors) and Sachin Gupta, Gupta Family Irrevocable Trust, Kurt Shintaffer, KCS 2012 GRAT, KDS 2012 GRAT, Paul McLachlan, Jesse Lee and Brian Bero, each of whom is herein referred to as a Founder.

Appdynamics Inc – Appdynamics, Inc. Sixth Amended and Restated Investors Rights Agreement (August 24th, 2016)

This Sixth Amended and Restated Investors Rights Agreement (this Agreement) is made as of November 8, 2015, by and among AppDynamics, Inc., a Delaware corporation (the Company), and the persons and entities (each, an Investor and collectively, the Investors) listed on Exhibit A hereto. Unless otherwise defined herein, capitalized terms used in this Agreement have the meanings ascribed to them in Section 1.